FASLG and diffuse large B-cell lymphoma: Despite this, DLBCL cells were resistant to both TRAIL and Fas ligand used in concentrations sufficient to induce killing of Jurkat cells (up to 10 ng/mL, data not shown and [22, 23]; Figure 2 and Supplementary Figure 1).